BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Deals

  Kush Bottles Closes Acquisition of Summit Innovations, LLC

  Kush Bottles, Inc. announced it has completed its acquisition of Summit Innovations, LLC.

  May 3, 2018

   · 

  4 min read
• Drug Development

  Eidos Therapeutics Initiates Phase 2 Clinical Trial for AG10 Targeting Transthyretin Amyloidosis Cardiomyopathy

  Eidos Therapeutics, Inc. announced dosing of the first patient in the Phase 2 clinical trial of AG10 in patients with ATTR cardiomyopathy (NCT03458130).

  May 3, 2018

   · 

  6 min read
• Business

  Milken Institute Global Gourmet Games Honors Dr. Richard Merkin With Inaugural Tommy Lasorda Leadership Award

  Dr. Richard Merkin, CEO and Founder of the Heritage Group, was honored by the Milken Institute Global Gourmet Games benefit with the Inaugural Tommy Lasorda Leadership Award.

  May 3, 2018

   · 

  4 min read
• Deals

  EVIO Inc. Closes Acquisition of Canadian Cannabis Testing Facility, Keystone Labs Inc.

  EVIO Inc. is pleased to announce that EVIO Canada has closed its previously announced acquisition of 50% stake in Keystone Labs Inc.

  May 3, 2018

   · 

  2 min read
• Business

  GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology

  GigaGen Inc. announced that Sheila M. Keating, Ph.D., has joined the company as Director, Immunology.

  May 3, 2018

   · 

  2 min read
• Biotech Beach

  OncoSec to Present at Eighth Annual BioNJ BioPartnering Conference

  OncoSec Medical Incorporated announced that Daniel J. O’Connor, Chief Executive Officer of OncoSec, will present at the Eighth Annual BioNJ BioPartnering Conference.

  May 3, 2018

   · 

  2 min read
• FDA

  Forty Seven, Inc. Granted Fast Track Designation for 5F9 for the Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

  Forty Seven, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted two Fast Track designations to its lead candidate, 5F9, for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

  May 3, 2018

   · 

  3 min read
• Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference

  Valeant Pharmaceuticals International, Inc. announced that Paul S. Herendeen, executive vice president, Finance, and chief financial officer, is scheduled to participate at the Goldman Sachs Third Annual Leveraged Finance Conference.

  May 3, 2018

   · 

  1 min read
• Business

  Nature Made® Enlists Influencer Collective To Kick-Start A Dialogue On What It Means To Be “Healthy Together”

  Nature Made announced it has partnered with Jeannine Morris.

  May 3, 2018

   · 

  5 min read
• Job Trends

  New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies

  The American Journal of Roentgenology recently published findings on statistical methods for downgrading the risk classification of breast masses to reduce the need for unnecessary breast biopsies.

  May 3, 2018

   · 

  6 min read